As previously announced on March 19, 2025, the Promissory Note had a term of 90 days and bore interest rate at an annual rate of 8%. Following the exercise of the Warrants, the Company's total ...

On May 13, 2025, the Company and ITIL entered into an amended and restated promissory note (the “A&R Note”) and a letter agreement relating to the A&R Note and amending the Pfizer License ...

You have to spend money to make money, as the old saying goes. But sometimes you have to borrow money to spend money, too.

The original promissory notes were issued to Inscobee Inc. on May 20, 2024, and August 19, 2024, in the principal amounts of $100,000 and $150,000, respectively. Another note was issued to Apimeds ...

The Promissory Note ensures sufficient short-term funding until the previously announced brokered and non-brokered private placements close, and bears interest at a rate of 12% per annum, with such ...

Petitioners were not entitled to interest deductions claimed on promissory notes related to a complex financial transaction, as the notes did not constitute genuine indebtedness for tax purposes, held ...

Neither the TSX Venture Exchange (“TSX-V”) nor its Regulation Services Provider (as that term is defined in the policies of the TSX-V) accepts responsibility for the adequacy or accuracy of ...

As previously announced on March 19, 2025, the Promissory Note had a term of 90 days and bore interest rate at an annual rate of 8%. Additionally, the Company announces the issuance of 19,950,000 ...

The original promissory notes were issued to Inscobee Inc. on May 20, 2024, and August 19, 2024, in the principal amounts of $100,000 and $150,000, respectively. Another note was issued to Apimeds ...

Mountain Crest Acquisition Corp. V secures $500,000 promissory note View all comments (0) 0 Latest comments Post Comment Guidelines Trade With A Regulated Broker Indices Commodities Bonds Stocks ...

On May 13, 2025, the Company and ITIL entered into an amended and restated promissory note (the "A&R Note”) and a letter agreement relating to the A&R Note and amending the Pfizer License Agreement.